Literature DB >> 23938220

Rheumatoid arthritis and risk of acute myocardial infarction--a nationwide retrospective cohort study.

Wei-Sheng Chung1, Cheng-Li Lin, Chiao-Ling Peng, Yung-Fu Chen, Chuan-Chin Lu, Fung-Chang Sung, Chia-Hung Kao.   

Abstract

OBJECTIVES: Rheumatoid arthritis (RA) imposes substantial social costs, including an increased risk of work-related disability and accelerated cardiovascular diseases. The aim of the study is to determine the risk of acute myocardial infarction (AMI) associated with RA in a nationwide retrospective cohort study.
METHODS: Using the catastrophic illness registry of the Taiwan National Health Insurance Research Database (NHIRD), we identified patients with RA from 1998 to 2010. We also randomly selected non-RA controls frequency-matched by age, sex, and index year from the general population free of RA. The risk of AMI was analyzed using Cox proportional hazards regression models including sex, age, and comorbidities.
RESULTS: From a total of 23.74 million people in the cohort, 29,260 RA patients and 117,040 controls were followed for 193,987 and 792,254 person-years, respectively. The incidence density rate increased in all groups of RA patients than those of the controls. RA patients had a 1.33-fold higher overall incidence of AMI than controls, with an adjusted hazard ration of 1.38. Although the overall adjusted hazard ratio of AMI increased with age, the age-specific RA patients to controls incidence rate ratio was higher for younger RA patients. Subjects with comorbidities of hypertension, diabetes hyperlipidemia, CVA, COPD, or ESRD had increased risk of AMI. Subjects with ESRD had the highest hazard of AMI.
CONCLUSION: This nationwide retrospective cohort study indicates that AMI risk increased by 38% in RA patients compared to the general population. Comorbidities increase the AMI risk independently.
© 2013.

Entities:  

Keywords:  Acute myocardial infarction; Cohort study; Rheumatoid arthritis

Mesh:

Year:  2013        PMID: 23938220     DOI: 10.1016/j.ijcard.2013.07.233

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  [Treatment of cardiovascular risk factors].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

2.  Sleep disorders associated with risk of rheumatoid arthritis.

Authors:  Wei-Sheng Chung; Cheng-Li Lin
Journal:  Sleep Breath       Date:  2018-02-10       Impact factor: 2.816

3.  The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.

Authors:  Khalid Almutairi; Johannes Nossent; David Preen; Helen Keen; Charles Inderjeeth
Journal:  Rheumatol Int       Date:  2020-11-11       Impact factor: 2.631

Review 4.  Methotrexate revisited: considerations for subcutaneous administration in RA.

Authors:  Randy Jay
Journal:  Clin Rheumatol       Date:  2014-11-30       Impact factor: 2.980

Review 5.  [Endocrinology and interdisciplinary consultation in internal medicine : Illustrated using the example of polyglandular autoimmune syndrome].

Authors:  G J Kahaly; J Zimmermann; M P Hansen; F Gundling; F Popp; M Welcker
Journal:  Internist (Berl)       Date:  2017-04       Impact factor: 0.743

6.  Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.

Authors:  Prashant Kaushik; Daniel H Solomon; Jeffrey D Greenberg; James T Anderson; George Reed; Ozlem Pala; Bahar Sumbul-Yuksel; Pooja Kadam; Joel M Kremer
Journal:  Clin Rheumatol       Date:  2015-08-05       Impact factor: 2.980

7.  Increased risk of stroke among hip fracture patients: a nationwide cohort study.

Authors:  C-H Tsai; C-L Lin; H-C Hsu; W-S Chung
Journal:  Osteoporos Int       Date:  2014-10-10       Impact factor: 4.507

Review 8.  Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence.

Authors:  Arduino A Mangoni; Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Matteo Piga; Gian Luca Erre
Journal:  Mediators Inflamm       Date:  2017-12-21       Impact factor: 4.711

9.  Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.

Authors:  Tzu-Chieh Lin; Daniel H Solomon; Sara K Tedeschi; Kazuki Yoshida; Yea-Huei Kao Yang
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

10.  Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years.

Authors:  Kun Zou; Fu-Kun Xiao; Hong-Ying Li; Qiao Zhou; Lu Ban; Min Yang; Chang-Fu Kuo; Weiya Zhang
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.